Product Images Butalbital, Acetaminophen, Caffeine And Codeine Phosphate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Butalbital, Acetaminophen, Caffeine And Codeine Phosphate NDC 68258-2012 by Dispensing Solutions, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
NDC 68258-2012-XX - NDC 68258 2012 XX NEXGEN PHARMA
This document provides information on a bulk source data of a medication capsule manufactured by Nexgen Pharma, Inc. The product has a dark blue/gray opaque capsule with the imprint "8 073" on the body in black ink. The bulk source NDC is 51991-0073-01, and the manufacturer lot is XXXXXX. The product contains Butalbital, Acetaminophen, Caffeine, and Codeine. The capsules are intended to be taken orally, and the recommended dose is a maximum of 6 capsules per day. It is advised not to consume alcohol while taking these capsules, as it can cause drowsiness or dizziness and impair one's ability to drive. The product should be dispensed in a tight/light resistant container. The document also provides information on the storage temperature and the lot number and expiry date of the medication. It contains a caution that federal law prohibits the transfer of this drug to anyone other than the patient for whom it was prescribed. It also warns not to keep the medication within children's reach. This information is intended for prescription use only.*
Chemical Structure - butalbital 02
Chemical Structure - butalbital 03
Chemical Structure - butalbital 04
Chemical Structure - butalbital 05
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.